Zelluna is a Norwegian biotechnology company developing T-cell receptor (TCR)-based natural killer (NK) cell therapies for cancer, with a focus on treating solid tumors. Its…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see ZELLUNA →Already a subscriber? Sign in
Xcout Intel tracks ZELLUNA continuously — this profile deepens as new filings, funding, people and hiring data arrive.